EdgarLookup

Essent Group Ltd. — Financial Data

Annual figures from SEC EDGAR XBRL filings (10-K)

These figures are extracted directly from XBRL-tagged financial statements that Essent Group Ltd. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.

Overview All Filings Annual Quarterly Insiders
54.7%
Profit Margin
Net income ÷ revenue
9.3%
Return on Assets
Net income ÷ assets
0.29x
Debt-to-Equity
Total liabilities ÷ equity
+1.5%
Revenue Growth
Year over year

Revenue

Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.26B Feb 18, 2026
FY2025 Dec 31, 2024 $1.24B Feb 18, 2026
FY2025 Dec 31, 2023 $1.11B Feb 18, 2026
FY2024 Dec 31, 2022 $1.00B Feb 19, 2025
FY2023 Dec 31, 2021 $1.03B Feb 16, 2024
FY2022 Dec 31, 2020 $955.15M Feb 17, 2023
FY2021 Dec 31, 2019 $867.57M Feb 16, 2022
FY2020 Dec 31, 2018 $719.35M Feb 26, 2021
FY2019 Dec 31, 2017 $576.51M Feb 18, 2020
FY2018 Dec 31, 2016 $458.26M Feb 19, 2019

Net Income

The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $689.97M Feb 18, 2026
FY2025 Dec 31, 2024 $729.40M Feb 18, 2026
FY2025 Dec 31, 2023 $696.39M Feb 18, 2026
FY2024 Dec 31, 2022 $831.35M Feb 19, 2025
FY2023 Dec 31, 2021 $681.78M Feb 16, 2024
FY2020 Dec 31, 2020 $123.60M Feb 26, 2021
FY2020 Sep 30, 2020 $124.54M Feb 26, 2021
FY2020 Jun 30, 2020 $15.38M Feb 26, 2021
FY2020 Mar 31, 2020 $149.52M Feb 26, 2021
FY2020 Dec 31, 2019 $146.96M Feb 26, 2021

Operating Cash Flow

Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $856.05M Feb 18, 2026
FY2025 Dec 31, 2024 $861.53M Feb 18, 2026
FY2025 Dec 31, 2023 $763.00M Feb 18, 2026
FY2024 Dec 31, 2022 $588.82M Feb 19, 2025
FY2023 Dec 31, 2021 $709.26M Feb 16, 2024
FY2022 Dec 31, 2020 $727.93M Feb 17, 2023
FY2021 Dec 31, 2019 $589.85M Feb 16, 2022
FY2020 Dec 31, 2018 $625.32M Feb 26, 2021
FY2019 Dec 31, 2017 $368.57M Feb 18, 2020
FY2018 Dec 31, 2016 $274.56M Feb 19, 2019

Capital Expenditures (Capex)

Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.36M Feb 18, 2026
FY2025 Dec 31, 2024 $6.77M Feb 18, 2026
FY2025 Dec 31, 2023 $4.00M Feb 18, 2026
FY2024 Dec 31, 2022 $3.98M Feb 19, 2025
FY2023 Dec 31, 2021 $2.50M Feb 16, 2024
FY2022 Dec 31, 2020 $2.45M Feb 17, 2023
FY2021 Dec 31, 2019 $3.41M Feb 16, 2022
FY2020 Dec 31, 2018 $4.05M Feb 26, 2021
FY2019 Dec 31, 2017 $2.78M Feb 18, 2020
FY2018 Dec 31, 2016 $3.16M Feb 19, 2019

Total Assets

The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $7.44B Feb 18, 2026
FY2025 Dec 31, 2024 $7.11B Feb 18, 2026
FY2024 Dec 31, 2023 $6.43B Feb 19, 2025
FY2023 Dec 31, 2022 $5.72B Feb 16, 2024
FY2022 Dec 31, 2021 $5.72B Feb 17, 2023
FY2021 Dec 31, 2020 $5.20B Feb 16, 2022
FY2020 Dec 31, 2019 $3.87B Feb 26, 2021
FY2019 Dec 31, 2018 $3.15B Feb 18, 2020
FY2018 Dec 31, 2017 $2.67B Feb 19, 2019
FY2017 Dec 31, 2016 $1.88B Feb 20, 2018

Total Liabilities

All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $1.68B Feb 18, 2026
FY2025 Dec 31, 2024 $1.51B Feb 18, 2026
FY2024 Dec 31, 2023 $1.32B Feb 19, 2025
FY2023 Dec 31, 2022 $1.26B Feb 16, 2024
FY2022 Dec 31, 2021 $1.49B Feb 17, 2023
FY2021 Dec 31, 2020 $1.34B Feb 16, 2022
FY2020 Dec 31, 2019 $888.58M Feb 26, 2021
FY2019 Dec 31, 2018 $784.25M Feb 18, 2020
FY2018 Dec 31, 2017 $733.93M Feb 19, 2019
FY2017 Dec 31, 2016 $539.23M Feb 20, 2018

Stockholders Equity

The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.76B Feb 18, 2026
FY2025 Dec 31, 2024 $5.60B Feb 18, 2026
FY2025 Dec 31, 2023 $5.10B Feb 18, 2026
FY2024 Dec 31, 2022 $4.46B Feb 19, 2025
FY2023 Dec 31, 2021 $4.24B Feb 16, 2024
FY2022 Dec 31, 2020 $3.86B Feb 17, 2023
FY2021 Dec 31, 2019 $2.98B Feb 16, 2022
FY2020 Dec 31, 2018 $2.37B Feb 26, 2021
FY2019 Dec 31, 2017 $1.94B Feb 18, 2020
FY2018 Dec 31, 2016 $1.34B Feb 19, 2019

Goodwill

An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $48.76M Feb 18, 2026
FY2025 Dec 31, 2024 $48.76M Feb 18, 2026
FY2025 Dec 31, 2023 $50.01M Feb 18, 2026
FY2025 Dec 31, 2022 $0 Feb 18, 2026

Retained Earnings

Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $5.26B Feb 18, 2026
FY2025 Dec 31, 2024 $4.69B Feb 18, 2026
FY2024 Dec 31, 2023 $4.08B Feb 19, 2025
FY2023 Dec 31, 2022 $3.49B Feb 16, 2024
FY2022 Dec 31, 2021 $2.75B Feb 17, 2023
FY2021 Dec 31, 2020 $2.15B Feb 16, 2022
FY2020 Dec 31, 2019 $1.81B Feb 26, 2021
FY2019 Dec 31, 2018 $1.28B Feb 18, 2020
FY2018 Dec 31, 2017 $815.08M Feb 19, 2019
FY2017 Dec 31, 2016 $436.34M Feb 20, 2018

Cash & Equivalents

Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.

Fiscal Year Period End Value Filed
FY2018 Dec 31, 2018 $64.95M Feb 19, 2019
FY2018 Dec 31, 2017 $43.52M Feb 19, 2019
FY2018 Dec 31, 2016 $27.53M Feb 19, 2019
FY2018 Dec 31, 2015 $24.61M Feb 19, 2019
FY2017 Dec 31, 2014 $24.41M Feb 20, 2018
FY2016 Dec 31, 2013 $477.66M Feb 16, 2017
FY2015 Dec 31, 2012 $22.32M Feb 29, 2016
FY2014 Dec 31, 2011 $18.50M Feb 27, 2015

EPS (Basic)

Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 18, 2026
FY2025 Dec 31, 2024 6 Feb 18, 2026
FY2025 Dec 31, 2023 6 Feb 18, 2026
FY2024 Dec 31, 2022 7 Feb 19, 2025
FY2023 Dec 31, 2021 6 Feb 16, 2024
FY2020 Dec 31, 2020 1 Feb 26, 2021
FY2020 Sep 30, 2020 1 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 1 Feb 26, 2021
FY2020 Dec 31, 2019 1 Feb 26, 2021

EPS (Diluted)

Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 6 Feb 18, 2026
FY2025 Dec 31, 2024 6 Feb 18, 2026
FY2025 Dec 31, 2023 6 Feb 18, 2026
FY2024 Dec 31, 2022 7 Feb 19, 2025
FY2023 Dec 31, 2021 6 Feb 16, 2024
FY2020 Dec 31, 2020 1 Feb 26, 2021
FY2020 Sep 30, 2020 1 Feb 26, 2021
FY2020 Jun 30, 2020 0 Feb 26, 2021
FY2020 Mar 31, 2020 1 Feb 26, 2021
FY2020 Dec 31, 2019 1 Feb 26, 2021

Shares Outstanding

Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 95.46M Feb 18, 2026
FY2025 Dec 31, 2024 105.02M Feb 18, 2026
FY2024 Dec 31, 2023 106.60M Feb 19, 2025
FY2023 Dec 31, 2022 107.68M Feb 16, 2024
FY2022 Dec 31, 2021 109.38M Feb 17, 2023
FY2021 Dec 31, 2020 112.42M Feb 16, 2022
FY2020 Dec 31, 2019 98.39M Feb 26, 2021
FY2019 Dec 31, 2018 98.14M Feb 18, 2020
FY2018 Dec 31, 2017 98.43M Feb 19, 2019
FY2017 Dec 31, 2016 93.11M Feb 20, 2018

Dividends Paid

Cash dividends distributed to common shareholders during the period. Shown as a positive value despite being a cash outflow in the SEC filing.

Fiscal Year Period End Value Filed
FY2025 Dec 31, 2025 $122.07M Feb 18, 2026
FY2025 Dec 31, 2024 $118.04M Feb 18, 2026
FY2025 Dec 31, 2023 $106.22M Feb 18, 2026
FY2024 Dec 31, 2022 $92.13M Feb 19, 2025
FY2023 Dec 31, 2021 $77.72M Feb 16, 2024
FY2022 Dec 31, 2020 $69.41M Feb 17, 2023
FY2021 Dec 31, 2019 $29.35M Feb 16, 2022
FY2020 Dec 31, 2018 $0 Feb 26, 2021
FY2019 Dec 31, 2017 $0 Feb 18, 2020